DE602006018205D1 - Verfahren zur herstellung eines oxaliplatins - Google Patents

Verfahren zur herstellung eines oxaliplatins

Info

Publication number
DE602006018205D1
DE602006018205D1 DE602006018205T DE602006018205T DE602006018205D1 DE 602006018205 D1 DE602006018205 D1 DE 602006018205D1 DE 602006018205 T DE602006018205 T DE 602006018205T DE 602006018205 T DE602006018205 T DE 602006018205T DE 602006018205 D1 DE602006018205 D1 DE 602006018205D1
Authority
DE
Germany
Prior art keywords
oxaliplatin
producing
preparation
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006018205T
Other languages
English (en)
Inventor
Vladimir Kysilka
Jan Mengler
Petr Kacer
Libor Cerveny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VUAB Pharma AS
Original Assignee
VUAB Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VUAB Pharma AS filed Critical VUAB Pharma AS
Publication of DE602006018205D1 publication Critical patent/DE602006018205D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
DE602006018205T 2006-06-08 2006-06-08 Verfahren zur herstellung eines oxaliplatins Active DE602006018205D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2006/005456 WO2007140804A1 (en) 2006-06-08 2006-06-08 A process for the preparation of an oxaliplatin

Publications (1)

Publication Number Publication Date
DE602006018205D1 true DE602006018205D1 (de) 2010-12-23

Family

ID=37745591

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006018205T Active DE602006018205D1 (de) 2006-06-08 2006-06-08 Verfahren zur herstellung eines oxaliplatins

Country Status (8)

Country Link
US (1) US7872150B2 (de)
EP (1) EP2029615B8 (de)
AT (1) ATE487730T1 (de)
AU (1) AU2006344273A1 (de)
CA (1) CA2652641A1 (de)
DE (1) DE602006018205D1 (de)
ES (1) ES2353531T3 (de)
WO (1) WO2007140804A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040186172A1 (en) * 2001-07-02 2004-09-23 Houssam Ibrahim Oxaliplatin active substance with a very low content of oxalic acid
AR072238A1 (es) * 2009-01-13 2010-08-18 Eriochem Sa Proceso para preparar derivados antineoplasicos neutros de platino (ii) grado farmaceutico con bajo contenido de plata
EP2208731B1 (de) 2009-06-26 2012-08-15 Umicore AG & Co. KG Verfahren zur Herstellung von 1,2-Diamino-Cyclohexan-Platin(II)-Komplexen
CZ302618B6 (cs) 2009-09-10 2011-08-03 Univerzita Palackého Cyklobutan-1,1-dikarboxylátokomplexy platiny s deriváty N6-benzyladeninu, zpusoby jejich prípravy a použití techto komplexu jako léciv v protinádorové terapii
CN101891771B (zh) * 2010-07-30 2012-12-12 重庆泰濠制药有限公司 一种制备奥沙利铂的方法
CN102643308B (zh) * 2012-05-11 2014-05-07 海南锦瑞制药股份有限公司 一种奥沙利铂结晶化合物及其冻干粉针剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041077B2 (ja) 1976-09-06 1985-09-13 喜徳 喜谷 1,2‐ジアミノシクロヘキサン異性体のシス白金(2)錯体
JPH0776230B2 (ja) * 1992-01-13 1995-08-16 田中貴金属工業株式会社 白金化合物の製造方法
JP3025602B2 (ja) 1993-05-21 2000-03-27 デビオファーム エス.アー. 光学的に高純度なシス−オキザラート(トランス−l−1,2−シクロヘキサンジアミン)白金(II)錯体の製造方法
JPH09278785A (ja) 1996-04-10 1997-10-28 Tanaka Kikinzoku Kogyo Kk 白金化合物の製造方法
DK1308454T3 (da) 1996-04-10 2005-08-01 Debiopharm Sa Fremgangsmåde til fremstilling af platinforbindelse
US20040186172A1 (en) 2001-07-02 2004-09-23 Houssam Ibrahim Oxaliplatin active substance with a very low content of oxalic acid
CZ297703B6 (cs) 2003-10-17 2007-03-07 Pliva-Lachema A.S. Oxaliplatina s nízkým obsahem doprovodných necistot a zpusob její výroby

Also Published As

Publication number Publication date
US20100174102A1 (en) 2010-07-08
AU2006344273A1 (en) 2007-12-13
EP2029615B1 (de) 2010-11-10
CA2652641A1 (en) 2007-12-13
EP2029615B8 (de) 2011-02-02
WO2007140804A8 (en) 2008-03-27
EP2029615A1 (de) 2009-03-04
ATE487730T1 (de) 2010-11-15
WO2007140804A1 (en) 2007-12-13
US7872150B2 (en) 2011-01-18
ES2353531T3 (es) 2011-03-02

Similar Documents

Publication Publication Date Title
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
MX337194B (es) Preparados, metodos y estuches utiles para el tratamiento de la tos.
EA024630B9 (ru) Производные пиразола как ингибиторы ионных каналов, активируемых высвобождением кальция (crac)
EP3722810A3 (de) Molekulare profilierung von tumoren
EA201001639A1 (ru) Композиции и способы их получения и применения
PH12018500641A1 (en) Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
DE602005014147D1 (de) Verfahren zur herstellung von hydrokolloiden
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
IN2012DN02737A (de)
ATE448319T1 (de) Verfahren zur herstellung eines stärkehydrolysats
MX2009004324A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hematologicas.
ATE473224T1 (de) Verfahren zur herstellung von nebivolol
MX2007011545A (es) Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
EA200701995A1 (ru) Способы уменьшения кальцификации
WO2010025321A3 (en) Method for treating multiple sclerosis patients with anti-il2r antibodies
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
ATE544566T1 (de) Verfahren zur herstellung von dünne metallnanodrähte durch biotemplating
DE602006017480D1 (de) Oxidkomplexlaminat, Verfahren zur Herstellung eines Oxidkomplexlaminats und Vorrichtung
ATE487730T1 (de) Verfahren zur herstellung eines oxaliplatins
UA96994C2 (ru) Производные 7-алкинил-1,8-нафтиридонов, способ их получения и их применения в терапии
WO2008060945A3 (en) Diagnosis and treatment of breast cancer
ATE516290T1 (de) Verfahren zur herstellung von buprenorphin und derivaten von buprenorphin
UA107576C2 (ru) Замещенные пиперидины
DE602006018067D1 (de) Verfahren zur sol-gel-verarbeitung
EA200970816A1 (ru) Новая лекарственная форма